Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

Beamion LUNG 2: A Phase III, Open-label, Randomized, Active-controlled, Multi-centre Trial Evaluating Orally Administered Zongertinib (BI 1810631) Compared With Standard of Care as First-line Treatment in Patients With Unresectable, Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer Harbouring HER2 Tyrosine Kinase Domain Mutations

INTERVENTIONALInicio: 9 de feb de 2024ID: NCT06151574

CompletadoFase 3ClinicalTrials.gov

A Phase 3 Efficacy and Safety Study of Ataluren (PTC124®) in Patients With Nonsense Mutation Cystic Fibrosis

INTERVENTIONALInicio: 1 de ago de 2014ID: NCT02139306

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Ceftriaxone in the Treatment of Adult Subjects With Community-Acquired Pneumonia

INTERVENTIONALInicio: 1 de jul de 2007ID: NCT00509106

ReclutandoFase 3ClinicalTrials.gov

A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)

INTERVENTIONALInicio: 4 de abr de 2025ID: NCT06801834

ReclutandoFase 1ClinicalTrials.gov

A Phase 1, First-time-in-human, Three-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK4527363 in Healthy Participants (Part A), Participants With Active Systemic Lupus Erythematosus (Part B), Healthy Participants of Chinese and Japanese Descent (Part C) and Participants With Interstitial Lung Disease Associated With Connective Tissue Disease (Part D)

INTERVENTIONALInicio: 2 de sept de 2024ID: NCT06576271

DesconocidoFase 3ClinicalTrials.gov

Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoC-2 Virus Infection (COVID-19). A Pilot, Randomized, Simple Blind, Placebo-controlled, Parallel-group Study

INTERVENTIONALInicio: 26 de jun de 2020ID: NCT04463264

Activo, no reclutaFase 2ClinicalTrials.gov

An Open-label Extension Study to Evaluate Safety and Tolerability of Sotatercept (MK-7962) Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care

INTERVENTIONALInicio: 12 de may de 2025ID: NCT06925750

ReclutandoClinicalTrials.gov

Advanced Wireless Sensors for Neonatal Care in the Delivery Room: the AWARD Prospective Multicenter International Study

INTERVENTIONALInicio: 8 de abr de 2025ID: NCT06693817

Activo, no reclutaFase 3ClinicalTrials.gov

A Randomized, Double-Blind Study to Compare Efficacy, Pharmacokinetics, Safety, and Immunogenicity Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

INTERVENTIONALInicio: 9 de sept de 2024ID: NCT06311721

ReclutandoFase 3ClinicalTrials.gov

TACTI-004, a Double-Blinded, Randomized Phase 3 Trial in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Receiving Eftilagimod Alfa (MHC Class II Agonist) in Combination With Pembrolizumab (PD-1 Antagonist) and Chemotherapy.

INTERVENTIONALInicio: 21 de mar de 2025ID: NCT06726265

TerminadoFase 2ClinicalTrials.gov

An Open-label Extension Study to Investigate Efficacy, Safety and Tolerability of LTP001 in Participants With Pulmonary Arterial Hypertension

INTERVENTIONALInicio: 27 de mar de 2023ID: NCT05764265

CompletadoFase 3ClinicalTrials.gov

An Open-label, Multicenter, Expanded Access Study of INC424 for Patients With Primary Myelofibrosis (PMF) or Post Polycythemia Myelofibrosis (PPV MF) or Post-essential Thrombocythemia Myelofibrosis (PET-MF).

INTERVENTIONALInicio: 16 de ago de 2011ID: NCT01493414

CompletadoFase 2ClinicalTrials.gov

A Phase 2 Randomized Study of BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer

INTERVENTIONALInicio: 3 de oct de 2022ID: NCT05005273

CompletadoClinicalTrials.gov

Continuous Positive Airway Pressure Decreased Lung Collapse During General Anesthesia Induction in Pediatric Patients

INTERVENTIONALInicio: 1 de mar de 2018ID: NCT03461770

CompletadoFase 1ClinicalTrials.gov

A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion (ANX-530) in Patients With Advanced Cancer.

INTERVENTIONALInicio: 1 de feb de 2007ID: NCT00432562

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension

INTERVENTIONALInicio: 1 de dic de 2009ID: NCT01106014

CompletadoClinicalTrials.gov

Retrospective Study for Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC in Argentina

OBSERVATIONALInicio: 26 de may de 2025ID: NCT07141563

CompletadoClinicalTrials.gov

EXPERT, EXPosurE Registry RiociguaT in Patients With Pulmonary Hypertension

OBSERVATIONALInicio: 31 de may de 2014ID: NCT02092818

TerminadoFase 2ClinicalTrials.gov

A 24-week, Multicenter, Randomized, Double-blind, Parallel-arm, Placebo-controlled Extension Study to Assess the Safety of CSJ117, When Added to Existing Standard of Care Asthma Therapy in Patients ≥18 Years of Age

INTERVENTIONALInicio: 8 de sept de 2021ID: NCT04946318

ReclutandoFase 3ClinicalTrials.gov

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

INTERVENTIONALInicio: 25 de mar de 2025ID: NCT06878261